Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 8:34 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2089–2112 of 15,643 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Activities. Clear all

Conditions: Alcohol Craving
Interventions: Not listed
Lead sponsor: Boston University; Other
Eligibility: 21 Years to 70 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Inadequate; Pulmonary Ventilation, Newborn, Infant, Very Low Birth Weight
Interventions: Nasal NIV-NAVA; Device
Lead sponsor: Tarah T Colaizy; Other
Eligibility: 7 Days to 1 Year
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 2
States / cities: Iowa City, Iowa

Conditions: Medication Refractory Epilepsy Patients With Electrodes Already Implanted Based on Clinical Criteria for Standard Monitoring
Interventions: model-based electrical brain stimulation; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Los Angeles, California • San Francisco, California

Conditions: Post-Concussion Syndrome
Interventions: Chiropractic adjustment; Procedure
Lead sponsor: Life University; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Marietta, Georgia

Conditions: Diabetes Mellitus, Type 2
Interventions: Exenatide-LAR plus Dapagliflozin placebo, Exenatide-LAR plus Dapagliflozin, Insulin Titration, Behavioral Therapy; Drug · Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Cancer
Interventions: Wearable; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Depressive Symptoms
Interventions: Resiliency Class, Case Management; Behavioral · Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 168 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 3
States / cities: Los Angeles, California • Torrance, California

Conditions: Osteoarthritis
Interventions: Diet & Exercise, Attention Control; Behavioral
Lead sponsor: Wake Forest University; Other
Eligibility: 50 Years and older
Enrollment: 823 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 3
States / cities: Chapel Hill, North Carolina • Waynesville, North Carolina • Winston-Salem, North Carolina

Conditions: Sedentary
Interventions: Community-based social networking intervention; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 21 Years and older
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Lowell, Massachusetts • Worcester, Massachusetts

Conditions: Sleep Disorder, Shift Work, Fatigue, Sleep Disturbance
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: Not listed
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Mild Cognitive Impairment
Interventions: Project 1 - Phase 2: VR Program for Social, Activity, and Cognitive Engagement, Project 1 - Phase 2: Tablet for Social, Activity, and Cognitive Engagement; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 60 Years and older
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Tallahassee, Florida • Champaign, Illinois • New York, New York

Conditions: Cognitive Impairment, Mild, Cognitive Decline
Interventions: Walking conversational reminiscence; Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 65 Years to 110 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Depression, End Stage Renal Disease
Interventions: Engagement Interview, Cognitive Behavioral Therapy, Antidepressant Drug Therapy; Behavioral · Drug
Lead sponsor: University of Washington; Other
Eligibility: 21 Years and older
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 3
States / cities: Albuquerque, New Mexico • Dallas, Texas • Seattle, Washington

Conditions: Multiple Myeloma, Heart Disease Risk Factors
Interventions: Oncology-Embedded Cardiovascular Risk Assessment Pathway, Primary Care Provider-Directed Cardiovascular Risk Assessment Pathway; Other
Lead sponsor: University of Vermont Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2028
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Hyperparathyroidism, Primary
Interventions: 18F-Fluorocholine, Positron Emission Tomography (PET); Drug · Procedure
Lead sponsor: Thomas Hope; Other
Eligibility: 13 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Diarrhea Infectious
Interventions: VENBETA6890, Placebo; Drug
Lead sponsor: Mark Klempner; Other
Eligibility: 18 Years to 45 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hypertension
Interventions: CHW; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years to 80 Years
Enrollment: 195 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Amputation
Interventions: Clinical Descriptive Measures related to amputation collected, GPS device education/distributed, activPAL device education/distributed, Questionnaire Assessments completed; Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Patellofemoral Pain Syndrome, Anterior Knee Pain Syndrome
Interventions: KneeStim mobile rehabilitation assistance device; Device
Lead sponsor: Articulate Labs; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Stroke, Fatigue
Interventions: Anodal transcranial direct current stimulation, Sham transcranial direct current stimulation; Device
Lead sponsor: Texas Woman's University; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Non Small Cell Lung Cancer, CNS Progression
Interventions: Temozolomide plus Osimertinib, Temozolomide plus Lorlatinib; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Blood Cancers
Interventions: EXERCISE TRAINING WITH OR WITHOUT MEDICATION; Other
Lead sponsor: VA Pittsburgh Healthcare System; Federal
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Alzheimer Disease (AD), Mild Cognitive Impairment (MCI)
Interventions: Metronome; Other
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 50 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Opioid Misuse, Trauma Injury
Interventions: Opioid Risk Monitoring (ORM), enhanced Trauma Care Coordination (eTCC), Pain Coping Skills Training - Brief (PCST-LITE), Standard Trauma Care Coordination (sTCC), Pain Coping Skills Training - Plus (PCST+), Pain Coping Skills Training - Maintenance (PCST-M); Other · Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 65 Years
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Madison, Wisconsin • Milwaukee, Wisconsin

Search by objective public record fields.

Quantitative EEG Assessment of Cue-Induced Changes in Brain Activity in Alcohol Use Disorders

Nasal Noninvasive NAVA in the Very Low Birth Weight Infant

Model-based Electrical Brain Stimulation

Post-concussion Syndrome and Chiropractic

Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes

Wearable Integration in Symptom Evaluation for Cancer Survivors

Building Resiliency and Increasing Community Hope

Weight Loss and Exercise for Communities With Arthritis in North Carolina

A Community-based Social Networking Intervention to Increase Walking in Dog Owners

Effect of Night Float Call on Sleep and Activity Patterns Among Anesthesia Residents

Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 1

Efficacy of a Multimodal Brain Health Intervention for Older African Americans

A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}

MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma

18F-Fluorocholine for the Detection of Parathyroid Adenomas

Study in Healthy Adults Challenged With Enterotoxigenic E. Coli, of the Safety, Tolerability and Anti-Diarrheal Activity of VENBETA6890, an Orally Administered, Human Monoclonal IgA

Scaling Community-Clinical Linkage Models to Address Diabetes and Hypertension Disparities in the Southeast United States

Assessing Ambulatory and Non-ambulatory Community Mobility in People With Lower Limb Amputation

Dynamic Quadriceps Muscle Stimulation for Treatment of Patellofemoral Pain

Behavioral and Neural Correlates of Post-Stroke Fatigue

Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease

Lifestyle Intervention for Veterans With Blood Cancer: Tele-Intervention

Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease

Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention